Medication info
Nutrasset Semi Tablet

Nutrasset Semi Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›18.75mg / 1 tablet
Manufacturer / importer
(Korea) Kyungbo Pharmaceutical
Appearance
Light yellow rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200709910 · Notified 2007.08.28 · Insurance code 665000210

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was given orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance below 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval for patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Children aged 12 years and older: An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 16 tablets should be taken in 1 day.

Ingredients

Manufacturer
(Korea) Kyungbo Pharmaceutical

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate pain
  • severe pain
  • acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly patients Administer the usual adult dose. However, since the elimination half-life of tramadol increased by 17% when tramadol was given orally to elderly patients aged 75 years or older, administer this medicine at intervals of at least 6 hours. Patients with renal impairment For patients with moderate renal impairment (creatinine clearance of 10-30ml/min), extend the dosing interval to 12 hours. Administration is not recommended for patients with severe renal impairment (creatinine clearance below 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, there is no need to readminister this medicine after dialysis to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval for patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Children aged 12 years and older: An initial dose of 4 tablets is recommended. Thereafter, doses should be given at intervals of at least 6 hours, and no more than 16 tablets should be taken in 1 day.

Precautions

This medication may burden the liver, so individuals who regularly consume more than three glasses of alcohol daily should consult a doctor or pharmacist. If a rash or hypersensitivity reaction occurs during the use of this medication, discontinue immediately and seek medical attention. Individuals with a history of seizures or at risk of seizures should exercise caution while on this medication due to the potential risk of seizures. Anaphylactic reactions, which can be life-threatening, may rarely occur with this medication, so anyone experiencing allergies should inform healthcare professionals immediately. Patients with acute and severe asthma can experience difficulty breathing while taking this medication, and it should only be used under medical supervision. Combining this medication with alcohol or central nervous system depressants can lead to severe sedation or respiratory depression, so such combinations should be avoided. Patients with head injuries or elevated intracranial pressure should be cautious as respiratory depression from this medication may worsen their condition. This medication can cause mental and physical dependence; hence, it should be taken under medical guidance for prolonged periods. Patients with impaired liver function must consult a doctor before taking this medication and should not exceed the recommended dosage. Rapid metabolizers with the CYP2D6 genotype may metabolize the active ingredient of this medication quickly, increasing the risk of respiratory depression, and should be cautious. This medication should not be administered to children under 12 years of age or adolescents under 18 years of age after certain surgeries. Patients with sleep apnea or at risk for hypoxia should continuously monitor for symptom exacerbation while on this medication. Elderly patients or those at risk for hyponatremia should monitor their serum sodium levels while on this medication. This medication may interact with certain drugs, so if taking other medications, it is essential to inform healthcare professionals. Pregnant or breastfeeding women must consult a doctor before using this medication, as it may affect the baby, especially during breastfeeding. Caution is needed as this medication can cause drowsiness or dizziness when driving or operating machinery.

Side effects

Liver damage, acute generalized rash with pustules, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, hepatotoxicity, hyponatremia, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, dyspepsia, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rashes, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervous hyperactivity, emotional instability, euphoria, decreased libido, sleep disorders, confusion, disorientation, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory reduction, tremor, sensory disturbances, attention deficit, syncope, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, visual disturbances, visual impairment, miosis, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, sweating, urinary disorders, erectile dysfunction, asthenia, chest pain, emotional abnormality, chills, chest discomfort, fatigue, thirst, irritability, feeling hot, weight loss, increased serum creatinine, anaphylactic reactions, emotional instability, delirium, suicidal ideation, muscle rigidity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, fixed rash, asthenia, fever, edema, rigidity, syncope, congestive heart failure, dizziness, confusion, exacerbation of migraine, involuntary contractions of muscles, respiratory distress, cough, bronchitis, urinary retention, frequent urination, abnormal kidney function test results, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, drowsiness, insomnia, loss of appetite, anxiety, depression, nervous hyperactivity, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, increased white blood cells, decreased platelets, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, bleeding, increased cholesterol, tinnitus, chills, hip pain, thigh pain, allergic rhinitis, nosebleeds, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, liver function abnormalities, nausea, dizziness, dyspnea, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, vomiting, dyspepsia, confusion, multiple organ failure, anaphylaxis, intentional overdose, chest discomfort, drug withdrawal syndrome, sweating, insomnia, rigidity, pain, upper respiratory tract syndrome, facial tics, agitation, nervous hyperactivity, hyperactivity, gastrointestinal symptoms, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system responses, toxic skin necrosis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed, airtight container and kept at room temperature between 1 and 30 degrees Celsius. This helps maintain the medication's efficacy and prevents deterioration.

Appearance and packaging

Appearance

Light yellow rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.